San Bruno, CA, United States of America

Steven E Anuskiewicz


Average Co-Inventor Count = 13.5

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2003-2007

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Steven E. Anuskiewicz

Introduction

Steven E. Anuskiewicz is a notable inventor based in San Bruno, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target inflammatory and autoimmune diseases. With a total of seven patents to his name, Anuskiewicz's work has the potential to impact many lives.

Latest Patents

Anuskiewicz's latest patents focus on antagonists of Monocyte Chemoattractant Protein-1 (MCP-1) function. These compounds are designed to prevent or treat chronic or acute inflammatory or autoimmune diseases. The diseases targeted include arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, Crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis, and transplant rejection. His patents also encompass pharmaceutical compositions that include these compounds and methods of treatment employing them.

Career Highlights

Throughout his career, Anuskiewicz has worked with various companies, including Telik, Inc. and Sanwa Kagaku Kenkyusho Co., Ltd. His experience in these organizations has contributed to his expertise in the pharmaceutical industry and the development of innovative treatments.

Collaborations

Anuskiewicz has collaborated with notable individuals in his field, including Edgardo Laborde and Louise Robinson. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Steven E. Anuskiewicz is a prominent inventor whose work in developing MCP-1 antagonists holds promise for treating various inflammatory and autoimmune diseases. His contributions to the pharmaceutical industry are noteworthy and reflect his commitment to innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…